Stericycle, Inc. (NASDAQ:SRCL) Given Average Rating of “Hold” by Brokerages

Stericycle, Inc. (NASDAQ:SRCL) has been assigned a consensus rating of “Hold” from the four brokerages that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $62.25.

Several equities analysts recently issued reports on the company. Wells Fargo & Company upped their price objective on Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research report on Friday, March 1st. Stifel Nicolaus upped their price target on Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a report on Thursday, February 29th. Truist Financial lifted their price objective on Stericycle from $50.00 to $57.00 and gave the stock a “hold” rating in a report on Thursday, February 29th. StockNews.com cut shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Finally, Robert W. Baird reduced their price target on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a research note on Friday.

Stericycle Stock Down 6.7 %

Shares of NASDAQ:SRCL opened at $46.51 on Friday. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.51. The stock has a fifty day simple moving average of $51.42 and a two-hundred day simple moving average of $48.15. Stericycle has a 12-month low of $37.78 and a 12-month high of $57.06. The stock has a market capitalization of $4.32 billion, a price-to-earnings ratio of -193.78, a PEG ratio of 2.68 and a beta of 1.09.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, beating the consensus estimate of $0.54 by $0.03. The company had revenue of $664.90 million for the quarter, compared to the consensus estimate of $676.42 million. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. Stericycle’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 EPS. On average, research analysts anticipate that Stericycle will post 2.32 earnings per share for the current fiscal year.

Institutional Trading of Stericycle

Large investors have recently added to or reduced their stakes in the business. Capital Research Global Investors grew its holdings in Stericycle by 13.4% during the fourth quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock valued at $296,762,000 after purchasing an additional 705,586 shares during the period. Sei Investments Co. grew its stake in shares of Stericycle by 35.5% during the 4th quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock valued at $52,601,000 after acquiring an additional 277,896 shares during the period. Ariel Investments LLC increased its holdings in Stericycle by 5.7% in the 3rd quarter. Ariel Investments LLC now owns 4,328,036 shares of the business services provider’s stock worth $193,506,000 after acquiring an additional 233,612 shares in the last quarter. Heartland Advisors Inc. raised its stake in Stericycle by 55.5% during the 4th quarter. Heartland Advisors Inc. now owns 583,545 shares of the business services provider’s stock worth $29,733,000 after acquiring an additional 208,256 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in Stericycle by 10.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider’s stock valued at $97,720,000 after purchasing an additional 192,045 shares in the last quarter. 98.82% of the stock is currently owned by institutional investors.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.